PRPF31 expression was significantly reduced (p < 0.001) in RPE derived from the three RP11 patients and the NPC, compared with control RPE, with the patient carrying the exon 2–8 deletion showing the lowest levels (Figure 4B). The gene discussed is PRPF31; the disease is nasopharyngeal carcinoma.